AdvisorNet Financial, Inc - SPDR SER TR ownership

SPDR SER TR's ticker is SPMD and the CUSIP is 78464A847. A total of 310 filers reported holding SPDR SER TR in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
AdvisorNet Financial, Inc ownership history of SPDR SER TR
ValueSharesWeighting
Q3 2023$65,925
+25.7%
1,505
+31.7%
0.01%
+50.0%
Q2 2023$52,452
-16.4%
1,143
-20.0%
0.00%
-33.3%
Q1 2023$62,746
+247.4%
1,428
+236.0%
0.01%
+200.0%
Q4 2022$18,063
+12.9%
4250.0%0.00%0.0%
Q3 2022$16,000
-15.8%
425
-12.6%
0.00%0.0%
Q2 2022$19,000
-62.0%
486
-54.1%
0.00%
-33.3%
Q1 2022$50,000
+8.7%
1,058
+15.0%
0.00%0.0%
Q4 2021$46,000
-40.3%
920
-44.7%
0.00%
-40.0%
Q3 2021$77,000
+492.3%
1,664
+490.1%
0.01%
+400.0%
Q2 2021$13,0000.0%2820.0%0.00%0.0%
Q1 2021$13,000
+18.2%
2820.0%0.00%0.0%
Q4 2020$11,000
+22.2%
2820.0%0.00%0.0%
Q3 2020$9,000
-10.0%
282
-13.8%
0.00%0.0%
Q2 2020$10,000
-68.8%
327
-74.2%
0.00%
-66.7%
Q1 2020$32,000
-93.8%
1,267
-91.1%
0.00%
-93.2%
Q4 2019$515,000
+25.0%
14,219
+17.1%
0.04%
+15.8%
Q3 2019$412,000
+36.4%
12,146
+36.9%
0.04%
+15.2%
Q2 2019$302,000
-12.7%
8,872
-14.6%
0.03%
-21.4%
Q1 2019$346,000
+24.9%
10,389
+10.3%
0.04%
+10.5%
Q4 2018$277,000
+443.1%
9,420
+562.9%
0.04%
+533.3%
Q3 2018$51,000
+4.1%
1,421
+1.7%
0.01%
-14.3%
Q2 2018$49,000
+81.5%
1,397
+70.0%
0.01%
+75.0%
Q1 2018$27,0008220.00%
Other shareholders
SPDR SER TR shareholders Q1 2021
NameSharesValueWeighting ↓
TIEDEMANN ADVISORS, LLC 6,702,683$333,374,00016.25%
WALLER FINANCIAL PLANNING GROUP, INC 786,685$39,130,0009.80%
Measured Wealth Private Client Group, LLC 487,279$24,237,0008.56%
ODonnell Financial Services, LLC 387,948$17,512,0008.09%
ARQ WEALTH ADVISORS, LLC 215,871$10,737,0007.63%
Peterson Wealth Advisors, LLC 494,976$24,620,0007.10%
Montz Harcus Wealth Management LLC 151,589$7,540,0006.60%
FLYNN ZITO CAPITAL MANAGEMENT, LLC 140,262$6,980,0005.92%
New Perspectives, Inc 165,406$8,227,0005.82%
Financial Strategies Group, Inc. 283,988$14,126,0005.76%
View complete list of SPDR SER TR shareholders